FORMULATION AND EVALUATION OF DASATINIB LOADED SOLID LIPID NANOPARTICLES
- Vol.10(12)
- M P Innovare Academic Sciences Pvt Ltd 2018
- 14-20p.
Objective: Method s: SLNs consist of a solid lipid matrix where the drug was incorporated . Surfactants of GRAS grade were used t o avoid aggregation and to stabilize the SLNs. DST -SLN s formulations of varying con centrations were prepared by high -speed homogenization technique and evaluated for drug excipients compatibility study, poly -dispersity index, particle size analysis, surface morphology, zeta potential , and drug release features. The aim of present work wa s to formulate and evaluate Dasatinib (DST) loaded solid lipid nanoparticles (SLNs) as a potential antic ancer drug delivery system by enhancing its solubility. Result s: It was observed that DST -SLNs with optimum quantities o f poloxome r: lecithin ratio showed 88.06% drug release in 6h with good entrapment efficiency of 76.9±0.84 % . Particle size, Polydispersity index, zeta potential and drug entrapment efficiency for the optimized formula tion was found to be optimum . Stability studies revealed that the entrapment efficiency of the SLN dispersion stored in 4 °C was stable. Conclusio n : Thus, it can be concluded that the formulations of DST loaded SLNs are suitable carriers for improving the solubility and dissolution related problems.